As high dose GM-CSF may play a pathogenic role by stimulating the differentiation of immunosuppressive MDSC and Treg cells [35], we further evaluated the influence of NK cell therapies on the accumulation of MDSCs and Tregs in the LLC tumor tissue. The gene discussed is CSF2; the disease is neoplasm.